4Suppliers
6Customers
2Debt Items
0Related Chains

Source-Backed Evidence Depth

Silo Pharma, Inc. (SILO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

22Total relationships
4Distinct source URLs
17High confidence
0.861Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Silo Pharma, Inc. Suppliers

TickerNameConfidenceEvidence
BLIND-FAITH-CONCEPTS-HOLDINGS-INC BLIND-FAITH-CONCEPTS-HOLDINGS-INC 92% On September 29, 2018, we entered into an Asset Purchase Agreement with Blind Faith Concepts Holdings, Inc. pursuant to which we completed the acquisition of 100% of the assets of NFID from the seller
MANY-ADS-INC MANY-ADS-INC 92% Pursuant to the Agreement, the Seller agreed to sell, and the Company agreed to purchase, certain software of the web-based application currently marketed as "QwikAgents"
COLUMBIA-UNIVERSITY COLUMBIA-UNIVERSITY 90% During a one-year period from the date of this agreement, we shall pay a total of $1,436,082 to Columbia University for the support of the research
ONE-LICENSOR ONE-LICENSOR 90% For the three months ended March 31, 2026 and 2025, one licensor accounted for 100 % of the Company's vendor license agreements (see Note 8) related to the Company's biopharmaceutical operations.

Silo Pharma, Inc. Customers

TickerNameConfidenceEvidence
ONE-LICENSEE ONE-LICENSEE 90% For the three months ended March 31, 2026 and 2025, one licensee accounted for 100 % total revenues from customer license fees.
AIKIDO-PHARMA-INC AIKIDO-PHARMA-INC 62% alance sheets. The Right shall be, to the full extent permitted by and on terms and conditions required by UMB, for a term consistent with the term of patent and technology licenses that UMB normally…
BLIND-FAITH-CONCEPTS-HOLDINGS-INC BLIND-FAITH-CONCEPTS-HOLDINGS-INC 62% ent companies under the Investment Company Act (“Investment Company Accounting”) which applied to prior periods. We determined that there is no cumulative effect of the change from Investment Company…
CO-LLC CO-LLC 62% 0.75 per share, are exercisable immediately upon issuance and will expire five years from the effective date of a registration statement registering for resale the underlying October 2025 Warrant Sha…
MANY-ADS-INC MANY-ADS-INC 62% alance sheets. The Right shall be, to the full extent permitted by and on terms and conditions required by UMB, for a term consistent with the term of patent and technology licenses that UMB normally…
NFID-LLC NFID-LLC 62% ent companies under the Investment Company Act (“Investment Company Accounting”) which applied to prior periods. We determined that there is no cumulative effect of the change from Investment Company…

Silo Pharma, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SILO-DEBT-12533 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.
SILO-DEBT-12532 Warrants outstanding: 250000 90% xbrl warrant detail from xbrl 2026-03-31.

Silo Pharma, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Silo Pharma, Inc..

Silo Pharma, Inc. Ownership

HolderNameConfidenceEvidence
SILO-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC Geode Capital Management, LLC 95% 13F/ownership overlay lists Geode Capital Management, LLC; shares held 92,905; ownership 0.09%; value $33,055; as of 2025-12-31.
SILO-OWNER-VANGUARD-GROUP-INC Vanguard Group Inc 95% 13F/ownership overlay lists Vanguard Group Inc; shares held 24,321; ownership 0.02%; value $8,653; as of 2025-12-31.
SILO-OWNER-VIRTU-FINANCIAL-LLC Virtu Financial LLC 95% 13F/ownership overlay lists Virtu Financial LLC; shares held 18,418; ownership 0.02%; value $6,553; as of 2025-12-31.
SILO-OWNER-DRW-SECURITIES-LLC DRW Securities, LLC 95% 13F/ownership overlay lists DRW Securities, LLC; shares held 333,733; ownership 0.34%; value $118,742; as of 2025-12-31.
SILO-OWNER-SUSQUEHANNA-INTERNATIONAL-GROUP-LLP Susquehanna International Group, LLP 95% 13F/ownership overlay lists Susquehanna International Group, LLP; shares held 29,577; ownership 0.03%; value $10,523; as of 2025-12-31.
SILO-OWNER-XTX-TOPCO-LTD Xtx Topco Ltd 95% 13F/ownership overlay lists Xtx Topco Ltd; shares held 56,899; ownership 0.06%; value $20,244; as of 2025-12-31.
SILO-OWNER-UBS-GROUP-AG UBS Group AG 95% 13F/ownership overlay lists UBS Group AG; shares held 6,043; ownership 0.01%; value $2,150; as of 2025-12-31.
SILO-OWNER-JANE-STREET-GROUP-LLC Jane Street Group, LLC 95% 13F/ownership overlay lists Jane Street Group, LLC; shares held 34,373; ownership 0.03%; value $12,229; as of 2025-12-31.
SILO-OWNER-STATE-STREET-CORPORATION State Street Corporation 95% 13F/ownership overlay lists State Street Corporation; shares held 12,500; ownership 0.01%; value $4,447; as of 2025-12-31.
SILO-OWNER-ADVISORSHARES-INVESTMENTS-LLC AdvisorShares Investments, LLC 95% 13F/ownership overlay lists AdvisorShares Investments, LLC; shares held 599,507; ownership 0.60%; value $213,304; as of 2025-12-31.

Silo Pharma, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.
🔐
SILO
Unlock SILO Supply Chain Data
Verified relationships include:
BLIND-FAITH-CONCEPTS-HOLDINGS-INCBLIND-FAITH-CONCEPTS-HOLD…Supplier92%
MANY-ADS-INCMANY-ADS-INCSupplier92%
ONE-LICENSEEONE-LICENSEECustomer90%
AIKIDO-PHARMA-INCAIKIDO-PHARMA-INCCustomer62%
+18 more relationships locked
Subscribe, View plans →